valsartan has been researched along with Arrhythmogenic Right Ventricular Dysplasia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gupta, R; Maitz, TN; Persin, K; Sundlof, DW | 1 |
| Metra, M | 1 |
2 other study(ies) available for valsartan and Arrhythmogenic Right Ventricular Dysplasia
| Article | Year |
|---|---|
Utilization of sacubitril-valsartan for right ventricular failure in a patient with arrhythmogenic right ventricular cardiomyopathy.
Topics: Adult; Aminobutyrates; Arrhythmogenic Right Ventricular Dysplasia; Biphenyl Compounds; Cardiomyopathies; Contrast Media; Diuretics; Drug Combinations; Female; Gadolinium; Heart Failure; Humans; Valsartan | 2022 |
August 2019 at a glance: arrhythmogenic cardiomyopathy, biomarkers of inflammation, insulin treatment, initiation of sacubitril/valsartan, and pharmacy-based intervention to increase medication adherence.
Topics: Aminobutyrates; Angiotensin Receptor Antagonists; Arrhythmogenic Right Ventricular Dysplasia; Biomarkers; Biphenyl Compounds; Drug Combinations; Humans; Hypoglycemic Agents; Inflammation; Insulin; Interleukin-6; Medication Adherence; Neprilysin; Tetrazoles; Valsartan | 2019 |